MEDBOT-B (02252.HK): Achieves First Semi-annual Profit; Projected Net Profit RMB28 Million – RMB40 Million

NewTimeSpace News: On 22 July 2026, Shanghai MicroPort MedBot (Group) Co., Ltd. (02252.HK) issued a positive profit alert. Based on preliminary review of the unaudited consolidated management accounts for the six months ended 30 June 2026, the Board anticipates the Group to register a net profit of roughly RMB28 million to RMB40 million, versus a net loss of RMB115 million in the corresponding period of last year. This represents the Group’s first semi-annual profit post-listing.

The swing from loss to profit stems from three key drivers. First, robust revenue growth: total revenue rose 200%–230% year-on-year. The Toumai laparoscopic surgical robot delivered strong momentum in both domestic and overseas markets, with overseas revenue climbing over 450% year-on-year. Second, notable gross margin improvement, up more than 15 percentage points versus the prior comparative period, supported by expanded production scale, continuous process optimisation and rapid growth in high-margin consumables revenue. Third, sustained expense discipline: operating expenses as a percentage of revenue declined visibly, lifting overall operational efficiency.

The Company reminded investors that the figures are preliminary estimates pending final confirmation. The interim results announcement is expected to be published on or before 31 August 2026.